Louisiana
5th Circuit Finds for Novartis, Affirming Dismissal of Aredia/Zometa Suit
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | May 27, 2014The U.S. Court of Appeals for the Fifth Circuit affirmed a summary judgment ruling in favor of Novartis Pharmaceuticals Corporation dismissing all of the plaintiff’s claims in a pharmaceutical products liability action arising out of the…
Louisiana Federal Court Grants Summary Judgment to Novartis After Excluding Plaintiff’s Expert Witnesses
Case | Products Liability & Toxic Torts | Pharmaceutical & Medical Device | June 14, 2013The U.S. District Court for the Western District of Louisiana granted Novartis Pharmaceuticals Corporation’s Daubert motion and so excluded plaintiff’s causation expert witnesses and then granted summary judgment in favor of Novartis in Perkins v. Novartis…
SABIC Granted Summary Judgment from the Bench in Louisiana State Court
Case | Business Interruption & Commercial Disputes | Products Liability & Toxic Torts | April 21, 2017Firm partner Matthew Malinowski appeared in the 23rd Judicial District Court in Ascension Parish, Louisiana to argue SABIC Petrochemicals’ motion for summary judgment. The case involved numerous personal injury claims brought by contract workers allegedly injured…
Louisiana Court of Appeal Overturns Trial Court Judgment for Plaintiff
Case | Products Liability & Toxic Torts | June 17, 2015The Louisiana Court of Appeal, Fourth Circuit, found that the trial court erred in granting plaintiff’s motion for partial summary judgment and reversed the judgment on the ground the trial court had misapplied the law of…